-
CCCC Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
C4 Therapeutics (CCCC)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 63.09 mm | 63.09 mm | 63.09 mm | 63.09 mm | 63.09 mm | 63.09 mm |
Cash burn (monthly) | 4.49 mm | 111.08 k | 9.41 mm | 9.94 mm | 8.04 mm | 5.94 mm |
Cash used (since last report) | 18.06 mm | 447.00 k | 37.88 mm | 40.02 mm | 32.37 mm | 23.89 mm |
Cash remaining | 45.03 mm | 62.65 mm | 25.21 mm | 23.08 mm | 30.72 mm | 39.20 mm |
Runway (months of cash) | 10.0 | 563.9 | 2.7 | 2.3 | 3.8 | 6.6 |
13F holders | Current |
---|---|
Total holders | 122 |
Opened positions | 33 |
Closed positions | 28 |
Increased positions | 38 |
Reduced positions | 30 |
13F shares | Current |
---|---|
Total value | 359.98 bn |
Total shares | 76.21 mm |
Total puts | 54.80 k |
Total calls | 669.50 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Lynx1 Capital Management | 6.88 mm | $39.22 bn |
Soleus Capital Management | 6.60 mm | $37.64 bn |
Soleus Capital Master Fund | 6.60 mm | $36.52 mm |
Wasatch Advisors | 5.68 mm | $32.36 bn |
Betta Investment | 5.57 mm | $35.30 mm |
BlackRock | 4.89 mm | $27.88 bn |
Ra Capital Management | 4.88 mm | $27.80 bn |
Orbimed Advisors | 4.38 mm | $24.95 bn |
Commodore Capital | 3.41 mm | $19.44 bn |
Vanguard | 3.37 mm | $19.21 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | Grogan Donna Roy | Common Stock | Grant | Acquire A | No | No | 3.66 | 3,757 | 13.75 k | 32,699 |
2 Jan 25 | Kenneth Carl Anderson | Common Stock | Grant | Acquire A | No | No | 3.66 | 3,074 | 11.25 k | 119,768 |
19 Nov 24 | Hoerter Steven L. | Stock Option Common Stock | Grant | Acquire A | No | No | 4.15 | 65,000 | 269.75 k | 65,000 |
7 Nov 24 | Scott N Boyle | Common Stock | Payment of exercise | Dispose F | No | No | 6.04 | 1,102 | 6.66 k | 56,567 |
7 Nov 24 | Scott N Boyle | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,750 | 0.00 | 57,669 |
7 Nov 24 | Scott N Boyle | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,750 | 0.00 | 10,500 |